San Diego, CA, United States of America

Isabella A Atencio


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Isabella A Atencio

Introduction

Isabella A Atencio is a notable inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of calpain inhibitors and their applications. Her innovative work has the potential to impact therapeutic strategies in various medical conditions.

Latest Patents

Isabella holds 1 patent titled "Calpain inhibitors and their applications." This invention provides a method to enhance apoptosis in a cell through the administration of p53 in combination with a calpain inhibitor. Additionally, it outlines methods for increasing the infectivity of a cell to a viral vector and enhancing transcription of a therapeutic transgene from the CMV promoter. The patent also describes methods to suppress the in vivo CTL response to viral vectors using calpain inhibitors. Furthermore, it includes pharmaceutical formulations of p53 and a calpain inhibitor in a pharmaceutically acceptable carrier, as well as methods for ablating neoplastic cells in a mammalian organism in vivo.

Career Highlights

Isabella is currently associated with Canji Inc., where she continues to advance her research and development efforts. Her work at Canji Inc. focuses on innovative solutions in the biotechnology sector, contributing to the company's mission of developing cutting-edge therapies.

Collaborations

Isabella collaborates with esteemed colleagues such as Drake M LaFace and Muralidhara Ramachandra. These partnerships enhance her research capabilities and foster innovation within her projects.

Conclusion

Isabella A Atencio is a pioneering inventor whose work on calpain inhibitors showcases her commitment to advancing medical science. Her contributions have the potential to lead to significant breakthroughs in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…